Optimizing canine T cell activation, expansion, and transduction
PLOS One · 2025
DOI: 10.1371/journal.pone.0324403 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Treyvon W Davis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, College of Veterinary Medicine, North Carolina State University, North Carolina, Raleigh, United States of America. Hauptthemen laut MEDLINE: Lymphocyte Activation, T-Lymphocytes, Transduction, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, National Institutes of Health.
Abstract (Originalsprache)
Dogs are becoming an important model for human cancers, and successfully troubleshooting issues with genetically modified T cell immunotherapy for round cell and solid neoplasms in dogs provides a unique opportunity to improve efficacy, safety, and affordability for humans as well. Unfortunately, T cell activation in dogs for optimal viral transduction has not been determined, restricting advancements in canine T cell immunotherapy. Two αCD3 and two αCD28 antibody clones for canine T cell stimulation have been described in the literature, but no studies have been undertaken to evaluate which αCD3/αCD28 combination is most effective, nor has anyone directly compared the efficacy of the two most popular antibody presentation strategies: antibody-coated plates and antibody-conjugated beads. In evaluating the effects of plate- or bead-bound αCD3 stimulation alone versus αCD3/αCD28 in combination, we tested 12 possible antibody stimulation strategies in addition to evaluating two largely unexplored mitogens in canine T cell transduction, phorbol myristate acetate (PMA) with ionomycin and concanavalin A (ConA). We investigated the impact of these stimulation strategies on canine T cell activation, expansion, and transduction. For stimulation strategies producing the best results, we also examined how each strategy affected the proportions of CD4/CD8 T cell subsets and regulatory T cell (T reg ) prevalence. We determined that, in general, plate-bound antibodies were far superior to bead-bound antibodies for canine T cell stimulation, and that plate-bound αCD3 clone CA17.6F9 in combination with αCD28 clone 5B8 or the mitogen PMA with ionomycin produced better activation and expansion profiles, better transduction, and more desirable T cell subsets that are more likely to improve patient outcomes in dogs suffering from round cell and solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, College of Veterinary Medicine, North Carolina State University, North Carolina, Raleigh, United States of America.
- Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, North Carolina, Raleigh, United States of America.
- College of Agriculture and Life Sciences, North Carolina State University, North Carolina, Raleigh, United States of America.
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
- Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, North Carolina, United States of America.
- Comparative Medicine Institute, North Carolina State University, Raleigh, North Carolina, United States of America.
ORCID-Profile: Paul R Hess, Yevgeny Brudno
Förderung
- NCI NIH HHS
- National Cancer Institute
- National Institutes of Health
- Comparative Medicine Institute, North Carolina State University
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
- North Carolina State University
- North Carolina State University - GG Scholars
- UNC Research
Zitieren
APA
Davis, T. W., Holmes, J. C., He, A., Hess, P. R., Mariani, C. L., & Brudno, Y. (2025). Optimizing canine T cell activation, expansion, and transduction. PLOS One. https://doi.org/10.1371/journal.pone.0324403
Vancouver
Davis TW, Holmes JC, He A, Hess PR, Mariani CL, Brudno Y. Optimizing canine T cell activation, expansion, and transduction. PLOS One. 2025. doi:10.1371/journal.pone.0324403
BibTeX
@article{Davis2025,
author = {Davis, Treyvon W and Holmes, Jennifer C and He, Arissa and Hess, Paul R and Mariani, Christopher L and Brudno, Yevgeny},
title = {Optimizing canine T cell activation, expansion, and transduction},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0324403}
}
EUVIMED